High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients.

@article{Geyer2015HighFH,
  title={High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients.},
  author={Lucia Bencke Geyer and S{\'e}rgio Saldanha Menna Barreto and Liese Loureiro Weigert and Adriane Ribeiro Teixeira},
  journal={Brazilian journal of otorhinolaryngology},
  year={2015},
  volume={81 6},
  pages={589-97}
}
INTRODUCTION The treatment of patients with cystic fibrosis involves the use of ototoxic drugs, mainly aminoglycoside antibiotics. Due to the use of these drugs, fibrocystic patients are at risk of developing hearing loss. OBJECTIVE To evaluate the hearing of patients with cystic fibrosis by High Frequency Audiometry and Distortion Product Otoacoustic Emissions. METHODS Cross-sectional study. The study group consisted of 39 patients (7-20 years of age) with cystic fibrosis and a control… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 50 references

Avaliação do uso da audiometria em frequências ultra - altas em pacientes submetidos ao uso de ototóxicos

  • LL Weigert, OB Piltcher, Procianoy EFA, CH Buss, SS Menna-Barreto
  • Bras Med
  • 2013

Fibrose Cística. In: Menna-Barreto SS, editor. Pneu- mologia no consultório

  • Dalcin PTR
  • Porto Alegre: Artmed;
  • 2009

Similar Papers

Loading similar papers…